INFLAMMATORY DISEASES

Lilly, a big name in medicine, is making a big move. They're buying Ventyx, a smaller company with a promising lineup of drugs. Ventyx's focus? Inflammation. They're working on small molecules that could treat a wide range of diseases caused by chronic inflammation. Think heart disease, brain disord

Inflammation is a big deal, and it's involved in many diseases that affect people worldwide. One specific receptor, called P2Y14, plays a crucial role in these inflammatory responses. Scientists have been working on new drugs to block this receptor and reduce inflammation. They used a process called